Some studies have suggested that the KD may induce insulin resistance and hepatic lipid accumulation by activating the PKCε and IL-INK signaling pathways.16,57 In addition, FXR regulates de novo lipid synthesis by inhibiting the expression of SREBP-1c. The gene discussed is SREBF1; the disease is Insulin resistance.